Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.153
-0.027 (-2.29%)
May 21, 2025, 3:13 PM - Market open

Adagio Medical Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-74.74-75.04-36.59-23.67
Depreciation & Amortization
1.331.390.530.5
Other Amortization
0.010.010.02-
Loss (Gain) From Sale of Assets
0.060.060-
Asset Writedown & Restructuring Costs
49.249.2--
Stock-Based Compensation
0.750.640.440.37
Other Operating Activities
-10.27-11.517.160.07
Change in Accounts Receivable
-00.04-0.070.03
Change in Inventory
1.160.63-2.980.04
Change in Accounts Payable
-5.64-4.562.820.44
Change in Other Net Operating Assets
8.29.693.01-0.17
Operating Cash Flow
-29.93-29.46-25.65-22.41
Capital Expenditures
-1.82-1.65-0.33-0.49
Sale of Property, Plant & Equipment
---0
Sale (Purchase) of Intangibles
---0.01-0.01
Investing Cash Flow
-1.82-1.65-0.34-0.5
Short-Term Debt Issued
---9.5
Long-Term Debt Issued
-16.523-
Total Debt Issued
6.516.5239.5
Long-Term Debt Repaid
--0.87-1.14-
Net Debt Issued (Repaid)
6.0615.6321.869.5
Issuance of Common Stock
--0.020.03
Financing Cash Flow
6.0615.6321.889.53
Foreign Exchange Rate Adjustments
0.10.21-0.050.08
Net Cash Flow
-25.59-15.27-4.16-13.31
Free Cash Flow
-31.75-31.11-25.99-22.9
Free Cash Flow Margin
-5512.50%-5167.28%-8661.67%-12118.52%
Free Cash Flow Per Share
-3.07-4.65-34.20-30.48
Cash Interest Paid
0.040.090.21-
Levered Free Cash Flow
-28.93-25.6-14.8-
Unlevered Free Cash Flow
-27.16-23.78-13.78-
Change in Net Working Capital
6.352.31-3.05-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q